DE3482905D1 - Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs. - Google Patents

Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs.

Info

Publication number
DE3482905D1
DE3482905D1 DE8484303310T DE3482905T DE3482905D1 DE 3482905 D1 DE3482905 D1 DE 3482905D1 DE 8484303310 T DE8484303310 T DE 8484303310T DE 3482905 T DE3482905 T DE 3482905T DE 3482905 D1 DE3482905 D1 DE 3482905D1
Authority
DE
Germany
Prior art keywords
cell
small
type
monoclonal antibodies
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484303310T
Other languages
English (en)
Inventor
James L Mulshine
John D Minna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Department of Commerce filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE3482905D1 publication Critical patent/DE3482905D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8484303310T 1983-05-18 1984-05-16 Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs. Expired - Fee Related DE3482905D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/495,725 US4569788A (en) 1983-05-18 1983-05-18 Monoclonal antibodies against non small cell lung cancer

Publications (1)

Publication Number Publication Date
DE3482905D1 true DE3482905D1 (de) 1990-09-13

Family

ID=23969768

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484303310T Expired - Fee Related DE3482905D1 (de) 1983-05-18 1984-05-16 Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs.

Country Status (8)

Country Link
US (1) US4569788A (de)
EP (1) EP0125928B1 (de)
JP (1) JPS60501309A (de)
AU (1) AU577293B2 (de)
CA (1) CA1230565A (de)
DE (1) DE3482905D1 (de)
DK (1) DK162531C (de)
WO (1) WO1984004599A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
US6294172B1 (en) 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
SE468231B (sv) * 1984-05-18 1992-11-23 Kabi Pharmacia Ab Foerfarande foer att paavisa smaacelligt lungcarcinomantigen och anvaendning av antikroppar mot fukosylsialosylgangliotetraos foer framstaellning av komposition foer behandling eller in vivo/ diagnos
SE455445B (sv) * 1984-08-28 1988-07-11 Pharmacia Ab Antikroppar mot sialosyllaktotetraos (iv?723neuaclcose?714) och antikroppens resp antigenets anvendning vid tumordiagnostik
EP0180413B1 (de) * 1984-10-26 1991-10-02 Wakunaga Seiyaku Kabushiki Kaisha Monoklonaler Antikörper gegen menschlichen Krebs
US4708930A (en) * 1984-11-09 1987-11-24 Coulter Corporation Monoclonal antibody to a human carcinoma tumor associated antigen
US4935495A (en) * 1984-12-21 1990-06-19 Oncogen Monoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomas
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
US4873188A (en) * 1985-05-28 1989-10-10 Oncogen Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies
EP0232871A3 (de) * 1986-02-07 1989-03-15 Yoshitomi Pharmaceutical Industries, Ltd. Menschlicher monoklonaler Antikörper, Hybridoma zu seiner Herstellung und seine Verwendung
US5185432A (en) * 1986-02-26 1993-02-09 Oncogen Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
JPS6319561A (ja) * 1986-07-11 1988-01-27 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
AU632469B2 (en) * 1988-04-04 1993-01-07 Johns Hopkins University, The A method for early detection of lung cancer
WO1990005540A1 (en) * 1988-11-23 1990-05-31 Administrators Of The Tulane Educational Fund Monoclonal antibodies specific for tumor antigens
DE3909799A1 (de) * 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
WO1991004040A1 (en) * 1989-09-15 1991-04-04 Biomeasure, Inc. Treatment of colon cancer
JP2000500322A (ja) 1995-10-02 2000-01-18 アメリカ合衆国 初期癌検出への使用のための上皮タンパク質及びそのｄｎａ
US5994062A (en) 1995-10-02 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Epithelial protein and DNA thereof for use in early cancer detection
US20020192717A1 (en) * 2001-03-23 2002-12-19 Kantor Aaron B. Cell-based assays for the simultaneous and discrete analysis of multiple analytes
WO2002081630A2 (en) * 2001-04-06 2002-10-17 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of semenogelin in the diagnosis, prognosis and treatment of cancer
CA2516191A1 (en) * 2003-02-14 2004-09-02 Salmedix, Inc Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
JP2009515141A (ja) 2005-07-21 2009-04-09 ウェイン ステート ユニバーシティー アスベスト曝露、胸膜中皮腫、および血清オステオポンチンレベル

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4317877A (en) * 1980-06-05 1982-03-02 Sloan Kettering Institute Process for detecting the presence of malignant and pre-malignant cells in humans

Also Published As

Publication number Publication date
DK21985A (da) 1985-01-17
EP0125928A2 (de) 1984-11-21
CA1230565A (en) 1987-12-22
EP0125928A3 (en) 1986-11-20
WO1984004599A1 (en) 1984-11-22
DK162531B (da) 1991-11-11
DK162531C (da) 1992-03-30
JPS60501309A (ja) 1985-08-15
DK21985D0 (da) 1985-01-17
EP0125928B1 (de) 1990-08-08
JPH0552193B2 (de) 1993-08-04
US4569788A (en) 1986-02-11
AU2966284A (en) 1984-12-04
AU577293B2 (en) 1988-09-22

Similar Documents

Publication Publication Date Title
DE3482905D1 (de) Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs.
DE3783277D1 (de) Monoklonaler antikoerper gegen humanes lungenkarzinom.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE3574730D1 (de) Monoklonaler antikoerper gegen ein humanes tumor-karzinom-assoziiertes antigen.
IT1219778B (it) Anticorpi aventi doppie specificita',loro preparazione e loro impieghi
FI844288A0 (fi) Antigen modifikation av polypeptider.
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
FI862761A (fi) Klonad antigen.
DE3885355D1 (de) Monoklonale Antikörper.
FI841549A (fi) Baeranordning foer patient.
DE3485712D1 (de) Monoklonale antikoerper gegen menschliche nierenkrebsantigene und verfahren.
IT1209577B (it) Sintesi dell'aspartame.
DE3684857D1 (de) Spezifischer monoklonaler antikoerper gegen menschliches lungenadenokarzinom.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DE3584280D1 (de) Monoklonaler antikoerper gegen menschlichen krebs.
IT1212097B (it) Sintesi dell'aspartame.
NO890116L (no) Monoklonale antistoffer.
FI873257A (fi) Monoklonala antikroppar foer specifika ige-ytreseptorer och dessa antikroppar producerande hybridcell-linjer och anvaendningen av anti-kroppar.
DE3882066D1 (de) Monoclonaler antikoerper gegen menschliches lungenadenokarzinom.
DE68913601D1 (de) Monoklonaler Antikörper gegen menschliches Lungenadenokarzinom.
FI834881A (fi) Foerfarande och anordning foer aostadkommande avstyrspaenning foer en hiss'likstroemsmotor.
ES267636Y (es) "lustrador".
ES264864Y (es) "pesacartas".
ATA179288A (de) Antikoerper gegen proteine
ES264428Y (es) "ceston plegable".

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee